Tech Company Financing Transactions

Foresight Diagnostics Funding Round

Foresight Diagnostics closed a $58.8 million Series B funding round on 4/27/2023. Investors included Foresite Capital, Agent Capital and Bluebird Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

12635 East Montview Blvd 224
Aurora, CO 80045
USA

Phone

Undisclosed

Website

www.foresight-dx.com

Email Address

[email protected]

Overview

Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) for aid in patient management that is funded by leading diagnostics VC firms in Silicon Valley. Foresight's cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Aurora, Colorado.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jake Chabon

        

Chief Medical Officer

Ash Alizadeh

        

Chief Operating Officer

Sandra Close

        

Browse more venture capital transactions:

Prev: 4/27/2023: Antiva Biosciences venture capital transaction
Next: 4/27/2023: Levitate venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary